Atherosclerosis biomarkers[4]

Anand Rohatgi
UT Southwestern · Current relationship

UT Southwestern · Current relationship
Anand Rohatgi is a preventive cardiologist whose research uses biomarkers and lipid biology, especially HDL function, to improve cardiovascular risk prediction in high-risk populations.
Rohatgi specializes in preventive cardiology. His research focuses on biomarkers for atherosclerosis and coronary artery disease, HDL function, inflammation, and excess cardiometabolic risk in populations including people with diabetes and South Asian ancestry.
Each topic is linked to its supporting source in Sources.
Training includes UT Southwestern Medical Center (Cardiology), University of Pennsylvania Health System (Internal Medicine), Duke University School of Medicine (M.D.), and M.D., plus 2 more records.
Explore education and trainingAs of 2008
As of 2005
As of 2002
Atherosclerosis biomarkers[4]
Coronary artery disease risk prediction[4]
Diabetes[4]
High-density lipoprotein[4]
Inflammation and atherosclerosis[4]
Lipid phenotyping[4]
Preventive cardiology[4]
South Asian cardiometabolic risk[4]